Delivery Order 47QTCA19D00FW-75N95C23F00012

Award Date 7/6/23
Potential Completion Date 7/5/24
Potential Value $247K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
North Potomac, MD 20878, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $245,238.24 firm fixed price delivery order against the Multiple Award Schedule to Digital Infuzion, Inc. for maintenance support of the National Center for Advancing Translational Sciences Inxight Drugs Fast Response Database and associated web application. Performance will take place in Potomac, Maryland through July 5, 2023. No set-aside designation was used...
This federal contract award to Digital Infuzion, LLC, a minority-owned small business, is for maintenance and support services for the National Center for Advancing Translational Sciences (NCATS) Inxight Drugs Fast Response Database (FRDB). The $248,731.84 fixed-price delivery order was issued under Digital Infuzion's existing Multiple Award Schedule (MAS) contract with the General Services Administration (GSA), which runs through July 2029 with a $475,000 ceiling. Digital Infuzion, which...
This is a $64,062.47 firm-fixed-price delivery order awarded to Digital Infuzion, LLC, a minority-owned small business, by the National Institutes of Health (NIH) Clinical Center. The order is for maintenance and electronic application development services, and is placed under the Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB) governmentwide acquisition contract. Digital Infuzion is a long-standing provider of IT services and solutions to the Department of...
This is a delivery order contract awarded by the Department of Health and Human Services National Institutes of Health Clinical Center to Digital Infuzion, Inc., a minority-owned, for-profit Subchapter S Corporation, for the maintenance of an electronic training program application system. The contract has a total potential value of $495,024.43 and is set aside for small businesses. It is issued under the Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB)...
This contract award to Digital Infuzion, LLC, a minority-owned software and healthcare IT services company based in Maryland, provides $1,940,570.00 in funding to the National Library of Medicine (NLM) for data center infrastructure modifications necessary to support the High Performance Computing Core Initiative. The award is a Firm Fixed Price Delivery Order issued under a General Services Administration (GSA) Multiple Award Schedule (MAS) contract, with a performance period from September...
This federal contract award is for $215,017.27 and was issued by the National Institutes of Health (NIH) to Digital Infuzion, LLC, a minority-owned, for-profit software and healthcare IT services company based in Gaithersburg, Maryland. The contract was awarded under the Chief Information Officer - Solutions and Partners 3 Small Business (CIO-SP3 SB) governmentwide acquisition contract, which is managed by the NIH. The contract has a total small business set-aside designation. Digital Infuzion...
This federal contract award was issued by the National Institutes of Information Technology Acquisition (NITAAC) Office, a civilian agency, to Digital Infuzion, LLC, a minority-owned, for-profit IT services company based in Rockville, Maryland. The $18,257,500.12 Delivery Order was awarded under the Chief Information Officer - Solutions and Partners 3 Small Business (CIO-SP3 SB) government-wide acquisition contract. The contract is for the ACF Program Management Module and does not have a...
This is a firm fixed-price delivery order awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Digital Infuzion, LLC, a minority-owned small business. The order was placed under the Chief Information Officer - Solutions and Partners 3 Small Business (CIO-SP3 SB) governmentwide acquisition contract. The award has a ceiling value of $190,033.31 and an ultimate completion date of August 5, 2020. Digital Infuzion, a...
This federal contract award was issued by the Securities and Exchange Commission (SEC) to Digital Infuzion, LLC, a minority-owned, for-profit software and healthcare IT services company. The $800,262.49 fixed-price delivery order contract was awarded under the Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB) government-wide acquisition contract vehicle. The contract is for IT services, with an ultimate completion date of October 31, 2016. It does not have a...
This is a $25,319,682.26 cost-plus-fixed-fee delivery order awarded by the National Institute on Aging (NIA) to Digital Infuzion, LLC, a minority-owned, for-profit software and healthcare IT services company. The task order is for project management, data safety monitoring board, and clinical research operations support services under NIA's $49.9 million Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract for centralized clinical research support services. Digital Infuzion previously...

Digital Infuzion, Inc. was awarded a $246,900 delivery order against its Multiple Award Schedule contract by the National Institutes of Health's National Center for Advancing Translational Sciences to provide maintenance support for the Inxight Drugs Fast Response Database. As part of its mission to accelerate the development and delivery of new drugs, the National Center for Advancing Translational Sciences maintains the database to facilitate sharing of drug safety and efficacy data among researchers. Digital Infuzion will support the database for one year through July 2024 on a firm fixed price basis, ensuring researchers continue to have access to this important resource as they work to translate scientific discoveries into new treatments for patients.

Generated 12/20/23, 2:50 AM